xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

457

ICAR SINONASAL TUMORS

2150. McDonald MW, Linton OR, Calley CSJ. Dose–volume rela tionships associated with temporal lobe radiation necrosis after skull base proton beam therapy. Int J Radiat Oncol Biol Phys . 2015;91(2):261-267. https://doi.org/10.1016/j.ijrobp.2014. 10.011 2151. Kitpanit S, Lee A, Pitter KL, et al. Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base. Int J Part Ther . 2020;6(4):17-28. https://doi.org/10.14338/ IJPT-20-00014.1 2152. Intensity-modulated or proton radiation therapy for sinonasal malignancy. ClinicalTrials.gov. Accessed March 23, 2022. https://clinicaltrials.gov/ct2/show/NCT01586767 2153. Han P, Wang X, Liang F, et al. Osteoradionecrosis of the skull base in nasopharyngeal carcinoma: incidence and risk factors. Int J Radiat Oncol Biol Phys . 2018;102(3):552-555. https://doi. org/10.1016/j.ijrobp.2018.06.027 2154. Leonetti JP, Weishaar JR, Gannon D, Harmon GA, Block A, Anderson DE. Osteoradionecrosis of the skull base. J Neu rooncol . 2020;150(3):477-482. https://doi.org/10.1007/s11060 020-03462-3 2155. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev . 2002;28(1):65-74. https://doi.org/10.1053/ctrv.2002.0254 2156. Huang XM, Zheng YQ, Zhang XM, et al. Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma. Laryngo scope . 2006;116(9):1626-1631. https://doi.org/10.1097/01.mlg. 0000230435.71328.b9 2157. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Random ized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol . 2003;21(13):2545-2550. https://doi.org/ 10.1200/JCO.2003.06.064 2158. Gavriel H, Eviatar E, Abu Eta R. Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: a 15-year single center experience: hyperbaric oxygen therapy for maxillary osteoradionecrosis. HeadNeck . 2017;39(2):275-278. https://doi. org/10.1002/hed.24577 2159. Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo controlled, double-blind trial from the ORN96 study group. J Clin Oncol . 2004;22(24):4893-4900. https://doi.org/10.1200/ JCO.2004.09.006 2160. Paniello RC, Fraley PL, O’Bert R. Effect of hyperbaric oxy gen therapy on a murine squamous cell carcinoma model: hyperbaric oxygen in SCC. HeadNeck . 2014;36(12):1743-1746. https://doi.org/10.1002/hed.23528 2161. Huang WB, Wong STS, Chan JYW. Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma. HeadNeck . 2018;40(2):369-376. https://doi.org/10.1002/hed.24973 2162. Habib A, Hanasono MM, DeMonte F, et al. Surgical manage ment of skull base osteoradionecrosis in the cancer population – treatment outcomes and predictors of recurrence: a case series. Operative Surg . 2020;19(4):364-374. https://doi.org/10. 1093/ons/opaa082 2163. Daoudi H, Labeyrie MA, Guillerm S, et al. Multimodal strategy for the management of sphenoid osteoradionecro-

2138. Spinelli BA, Galantino ML, Eden MM, Flores AM. Rec ommendations for patient-reported outcome measures for head and neck cancer-related neck dysfunction: a system atic review. Rehabil Oncol . 2014;32(3):20-31. https://doi.org/10. 1097/01893697-201432030-00004 2139. Van Hinte G, Sancak T, Weijs WLJ, et al. Effect of elective neck dissection versus sentinel lymph node biopsy on shoul der morbidity and health-related quality of life in patients with oral cavity cancer: a longitudinal comparative cohort study. Oral Oncol . 2021;122:105510. https://doi.org/10.1016/j. oraloncology.2021.105510 2140. Nilsen ML, Lyu L, Belsky MA, et al. Impact of neck disability on health-related quality of life among head and neck can cer survivors. Otolaryngol Head Neck Surg . 2020;162(1):64-72. https://doi.org/10.1177/0194599819883295 2141. Terezakis SA, Bohle GC, Lee NY. Fistula formation after post operative radiation treatment for paranasal sinus cancer. Am J Clin Oncol . 2008;31(2):199-204. https://doi.org/10.1097/COC. 0b013e31815aff43 2142. Shaw E, Arusell R, Scheithauer B, et al. Prospective ran domized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a north central cancer treatment group/radiation therapy oncology group/eastern cooperative oncology group study. J Clin Oncol . 2002;20(9):2267-2276. https://doi.org/10.1200/ JCO.2002.09.126 2143. Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensity-modulated radiation therapy versus conven tional radiotherapy. Am J Clin Oncol . 2005;28(4):351-358. https://doi.org/10.1097/01.coc.0000158826.88179.75 2144. Wang K, Zanation AM, Chera BS. The role of radiation ther apy in the management of sinonasal and ventral skull base malignancies. Otolaryngol Clin North Am . 2017;50(2):419-432. https://doi.org/10.1016/j.otc.2016.12.014 2145. Adeberg S, Akbaba S, Lang K, et al. The Phase 1/2 ACCEPT trial: concurrent cetuximab and intensity modulated radi ation therapy with carbon ion boost for adenoid cystic carcinoma of the head and neck. Int J Radiat Oncol Biol Phys . 2020;106(1):167-173. https://doi.org/10.1016/j.ijrobp.2019. 09.036 2146. Koto M, Hasegawa A, Takagi R, et al. Risk factors for brain injury after carbon ion radiotherapy for skull base tumors. Radiother Oncol . 2014;111(1):25-29. https://doi.org/10.1016/j. radonc.2013.11.005 2147. Fan D, Kang JJ, Fan M, et al. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers. OralOncol . 2020;104:104641. https://doi.org/10.1016/ j.oraloncology.2020.104641 2148. Jones B, McMahon SJ, Prise KM. The radiobiology of proton therapy: challenges and opportunities around relative biolog ical effectiveness. Clin Oncol . 2018;30(5):285-292. https://doi. org/10.1016/j.clon.2018.01.010 2149. McDonald MW, Liu Y, Moore MG, Johnstone PAS. Acute tox icity in comprehensive head and neck radiation for nasophar ynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol . 2016;11(1):32. https://doi.org/10.1186/ s13014-016-0600-3